Introduction

Danaher Corporation is a major American science and technology company focused on healthcare, diagnostics, life sciences and biotechnology. Unlike a traditional medical-device manufacturer that primarily produces hospital equipment, Danaher operates through a large group of specialised businesses that develop laboratory instruments, diagnostic systems, scientific research tools, biotechnology equipment, software and technologies used to develop modern medicines.

Danaher’s current business structure is organised into three major segments:

• Diagnostics
• Life Sciences
• Biotechnology

The company operates through more than 15 businesses across these fields and uses its Danaher Business System (DBS) to drive continuous improvement, innovation and operational efficiency. Danaher reported $24.568 billion in total sales for 2025, with Diagnostics contributing $9.941 billion, Life Sciences $7.334 billion and Biotechnology $7.293 billion.

---

What Does Danaher Make?

Danaher is not one single product manufacturer. Instead, it owns and operates numerous specialised companies that make products and technologies for laboratories, hospitals, researchers, pharmaceutical companies and biotechnology manufacturers.

Its portfolio includes:

• Clinical laboratory analysers
• Immunoassay systems
• Molecular diagnostic systems
• PCR testing systems
• Blood-gas analysers
• Point-of-care diagnostic devices
• Cancer pathology equipment
• Digital pathology technologies
• Microscopes
• Flow cytometry systems
• Cell-analysis instruments
• Mass spectrometers
• Chromatography systems
• Laboratory software
• Genomics tools
• Antibodies and research reagents
• Bioreactors
• Bioprocessing equipment
• Filtration and purification systems
• Cell and gene-therapy manufacturing technologies
• Scientific imaging systems

Danaher describes its ecosystem as a group of science and technology businesses working across biotechnology, diagnostics and life sciences.

---

1. Danaher Diagnostics

Diagnostics is one of Danaher’s largest business segments.

Danaher’s diagnostics businesses provide technologies used to identify diseases, monitor patients and provide information that helps healthcare professionals make treatment decisions.

The company’s diagnostics portfolio covers:

• Clinical laboratory testing
• Molecular diagnostics
• Point-of-care testing
• Blood-gas analysis
• Cancer diagnostics
• Pathology
• Breast biopsy technologies
• Patient monitoring
• Laboratory automation
• Diagnostic software

Danaher says its diagnostics businesses operate across six continents and serve settings ranging from local clinics and physicians’ offices to major trauma, cancer and critical-care centres.

---

2. Beckman Coulter Diagnostics

Beckman Coulter is one of the most important companies within Danaher’s Diagnostics segment.

It develops systems designed to automate and simplify biomedical laboratory testing.

Its portfolio includes technologies for:

• Clinical chemistry
• Immunoassays
• Haematology
• Microbiology
• Laboratory automation
• Clinical laboratory workflow
• Diagnostic testing

Beckman Coulter’s systems are used by hospitals and diagnostic laboratories for high-volume testing.

Danaher describes Beckman Coulter as a developer, manufacturer and marketer of products designed to simplify and automate complex biomedical testing.

---

3. Clinical Chemistry and Immunoassay

Through businesses such as Beckman Coulter Diagnostics, Danaher provides automated laboratory systems for clinical chemistry and immunoassay testing.

These technologies can help laboratories measure:

• Glucose
• Lipids
• Enzymes
• Proteins
• Electrolytes
• Hormones
• Cardiac biomarkers
• Other clinical markers

Immunoassays can be used for applications involving hormones, infectious diseases, cardiac testing and other biomarkers.

---

4. Beckman Coulter DxI 9000

The DxI 9000 Immunoassay Analyzer is one example of Danaher’s current diagnostic technology portfolio.

It is designed for automated immunoassay testing in clinical laboratories.

In 2025, Beckman Coulter expanded the assay menu associated with the DxI 9000 platform, including progress in assays related to neurodegenerative diseases.

---

5. Cepheid Molecular Diagnostics

Cepheid is another important Danaher diagnostics business.

Cepheid focuses on molecular diagnostic systems and tests designed to provide rapid results.

Its GeneXpert platform is one of its best-known technologies.

The system uses automated molecular testing cartridges and instruments to detect genetic material associated with specific diseases or pathogens.

Applications can include:

• Infectious diseases
• Respiratory infections
• Tuberculosis
• Gastrointestinal infections
• Sexual-health infections
• Healthcare-associated infections
• Other molecular testing applications

Danaher describes Cepheid as a company focused on accurate, easy-to-use molecular systems and tests.

---

6. Xpert Molecular Tests

Cepheid’s Xpert test family includes cartridge-based molecular assays.

One major advantage of this approach is that multiple stages of molecular testing can be integrated into an automated workflow.

In 2025, Cepheid received FDA clearance for the Xpert GI Panel, a multiplex PCR test designed to detect 11 common gastrointestinal pathogens from a single patient sample.

---

7. HemoCue Point-of-Care Diagnostics

HemoCue is part of Danaher’s Diagnostics group.

It specialises in near-patient or point-of-care testing.

Point-of-care diagnostics can allow certain tests to be performed close to the patient rather than sending every sample to a central laboratory.

Applications can include:

• Haemoglobin testing
• Glucose testing
• Other near-patient measurements

Danaher identifies HemoCue as a global leader in point-of-care diagnostics.

---

8. Radiometer Blood-Gas Diagnostics

Radiometer is another Danaher Diagnostics business.

It develops systems for blood-gas and critical-care testing.

Blood-gas analysis can provide important information about:

• Oxygenation
• Carbon dioxide
• Acid-base balance
• Electrolytes
• Metabolic status

Radiometer reports that its equipment is used to analyse a very large number of blood samples worldwide. Danaher describes Radiometer as a major provider of blood-gas testing technology.

---

9. Cancer Diagnostics

Danaher also has a strong presence in cancer diagnostics.

Leica Biosystems is a major company within Danaher’s Diagnostics portfolio.

Its technologies support pathology laboratories and cancer diagnosis workflows.

The portfolio can include:

• Tissue preparation
• Histology
• Tissue staining
• Immunohistochemistry
• Pathology instruments
• Digital pathology
• Image analysis
• Workflow solutions

Danaher describes Leica Biosystems as a cancer-diagnostics company and global leader in pathology workflow solutions.

---

10. Digital Pathology

Digital pathology converts conventional pathology slides into digital images that can be reviewed and analysed using computer systems.

Danaher’s pathology businesses are involved in technologies supporting:

• Digital slide scanning
• Image management
• Pathology workflows
• Image analysis
• AI-supported pathology applications

Digital pathology can help laboratories improve collaboration, workflow management and access to advanced image-analysis tools.

---

11. Mammotome Breast Biopsy Technology

Mammotome is another Danaher Diagnostics business.

It focuses on breast-biopsy technologies.

Its products are designed to support clinicians during breast-biopsy procedures and include technologies associated with tissue sampling and biopsy marking.

Danaher describes Mammotome as a global leader in breast-biopsy markers and related solutions.

---

12. Masimo Monitoring Technologies

Danaher’s Diagnostics portfolio also includes Masimo, a company known for patient-monitoring technologies.

Masimo has developed technologies associated with:

• Pulse oximetry
• Oxygen saturation monitoring
• Patient monitoring
• Non-invasive measurements
• Hospital monitoring workflows

Danaher identifies Masimo as a diagnostics business focused on monitoring technologies designed to improve patient outcomes and clinical workflows.

---

13. Life Sciences Business

Danaher’s second major area is Life Sciences.

Life Sciences companies provide tools used by scientists to understand biology, study diseases, develop medicines and perform advanced laboratory research.

Danaher says its Life Sciences businesses support activities ranging from disease research and pharmaceutical development to food and water testing and biopharmaceutical research.

---

14. Beckman Coulter Life Sciences

Beckman Coulter Life Sciences develops laboratory instruments used in research and scientific analysis.

Its technologies include:

• Flow cytometry
• Cell analysis
• Particle analysis
• Laboratory automation
• Research instruments
• Cell-counting technologies

These systems can be used by universities, research institutions, pharmaceutical companies and biotechnology laboratories.

---

15. Leica Microsystems

Leica Microsystems develops high-precision optical and scientific instruments.

Its portfolio includes:

• Research microscopes
• Surgical microscopes
• Confocal microscopy
• Digital imaging
• Industrial microscopy
• Scientific imaging technologies

These systems allow scientists and medical professionals to examine structures at microscopic scales.

Danaher identifies Leica Microsystems as a developer of microscopes and scientific instruments.

---

16. Molecular Devices

Molecular Devices provides laboratory technologies used for biological research and drug discovery.

Its product areas include:

• Microplate readers
• Imaging systems
• Cell-analysis systems
• Automated cell counters
• Screening technologies
• Laboratory software

These tools are useful for pharmaceutical research, biotechnology and academic laboratories.

---

17. SCIEX Mass Spectrometry

SCIEX is another major Danaher Life Sciences business.

It develops analytical instruments and technologies, particularly in mass spectrometry.

Mass spectrometers can help scientists identify and quantify molecules.

Applications include:

• Drug development
• Pharmaceutical analysis
• Proteomics
• Metabolomics
• Food testing
• Environmental testing
• Clinical research

In 2025, SCIEX introduced the ZenoTOF 8600 high-resolution mass spectrometer, aimed at helping researchers accelerate drug-development workflows.

---

18. Phenomenex Chromatography

Phenomenex provides chromatography products and technologies.

Chromatography is widely used to separate, identify and analyse chemical compounds.

Phenomenex products can support:

• Pharmaceutical research
• Drug analysis
• Biopharmaceutical research
• Food testing
• Environmental analysis
• Chemical analysis

Danaher describes Phenomenex as a provider of chromatography solutions designed to accelerate scientific research.

---

19. Pall Filtration and Separation

Pall Corporation provides filtration, separation and purification technologies.

Its products are used across scientific and industrial applications, including biotechnology and pharmaceutical manufacturing.

Applications include:

• Bioprocess filtration
• Sterile filtration
• Fluid purification
• Laboratory filtration
• Pharmaceutical manufacturing
• Biopharmaceutical production

Danaher identifies Pall as a global leader in filtration, separation and purification.

---

20. Abcam Research Tools

Abcam is part of Danaher’s Life Sciences portfolio.

Abcam develops research tools including:

• Antibodies
• Assays
• Protein-related research products
• Cell and molecular biology research tools

Researchers can use these products to investigate proteins, pathways and disease mechanisms.

Danaher describes Abcam’s products as highly validated research tools supporting scientific, diagnostic and therapeutic research.

---

21. Integrated DNA Technologies

Integrated DNA Technologies (IDT) provides products used in molecular biology and genomics.

Its portfolio includes:

• Synthetic DNA
• RNA products
• Oligonucleotides
• Gene-editing components
• Molecular biology reagents
• Next-generation sequencing-related products

These technologies are used in research, diagnostics and biotechnology.

Danaher states that IDT products are used in diagnostic tests covering many cancer, inherited and infectious diseases.

---

22. Genomics and Molecular Research

Danaher’s life-sciences ecosystem supports genomic research through multiple companies.

Genomics technologies can be used to study:

• DNA
• RNA
• Genetic mutations
• Gene expression
• Cancer biology
• Inherited disorders
• Infectious organisms
• Gene-editing systems

This makes Danaher relevant to the rapidly developing field of precision medicine.

---

23. Biotechnology Segment

Danaher’s third major segment is Biotechnology.

The biotechnology business is led by Cytiva and provides technologies, services and expertise used to develop and manufacture biological medicines.

These technologies are particularly important for:

• Monoclonal antibodies
• Vaccines
• Cell therapies
• Gene therapies
• Recombinant proteins
• Other biologic medicines

Danaher says its biotechnology businesses support customers from discovery through manufacturing and delivery of next-generation therapeutics.

---

24. Cytiva

Cytiva is one of Danaher’s most important biotechnology businesses.

It provides technologies used throughout biopharmaceutical manufacturing.

Its portfolio includes:

• Bioreactors
• Chromatography systems
• Filtration systems
• Cell-culture technologies
• Protein purification
• Single-use technologies
• Process development systems
• Bioprocessing equipment

Cytiva helps pharmaceutical and biotechnology companies manufacture biological medicines at commercial scale.

---

25. Bioreactors

Bioreactors provide controlled environments in which cells can grow and produce biological products.

Cytiva develops bioreactor technologies for research and manufacturing.

In 2025, Cytiva expanded its Xcellerex X-platform bioreactor with 500-litre and 2,000-litre formats.

Such technologies can support the production of biologics and other advanced therapies.

---

26. Cell and Gene Therapy

Danaher plays an important role in technologies supporting cell and gene therapies.

Its companies provide tools for:

• Cell processing
• Gene therapy manufacturing
• Viral-vector production
• DNA and RNA technologies
• Cell expansion
• Purification
• Quality control

These technologies help researchers and pharmaceutical manufacturers move therapies from laboratory research toward commercial production.

---

27. Aldevron

Aldevron is another Danaher biotechnology business.

It provides critical nucleic acids and proteins used in applications such as:

• Gene therapies
• Cell therapies
• Gene editing
• DNA vaccines
• RNA vaccines

Danaher identifies Aldevron as a provider of critical nucleic acids and proteins for these advanced biotechnology applications.

---

28. Biotechnology Manufacturing

Danaher’s biotechnology businesses help pharmaceutical companies manufacture complex biological products.

The manufacturing process can involve:

Cell culture → Bioreactor → Harvesting → Filtration → Chromatography → Purification → Formulation → Final product

Danaher companies provide technologies across many of these stages.

This makes the company important not only in laboratory research but also in large-scale biopharmaceutical manufacturing.

---

29. Danaher Business System

One of the distinctive features of Danaher is its Danaher Business System (DBS).

DBS is a management and continuous-improvement system used across Danaher’s businesses.

Its philosophy focuses on:

• Continuous improvement
• Quality
• Efficiency
• Customer needs
• Innovation
• Problem solving
• Operational discipline

Danaher says DBS helps its businesses collaborate and continuously improve their products, services and operations.

---

30. Artificial Intelligence and Digital Technologies

Danaher is also investing in digital technologies and artificial intelligence.

The company identifies AI as one of the areas where science and technology can improve healthcare and life-sciences workflows.

Potential applications include:

• Diagnostic image analysis
• Digital pathology
• Laboratory automation
• Data analysis
• Drug discovery
• Bioprocess optimisation
• Clinical decision support

Danaher says its science strategy includes precision diagnostics, genomic medicine, next-generation biomanufacturing and AI-enabled solutions.

---

31. Major Danaher Companies

Some of the important businesses within Danaher’s current ecosystem include:

Diagnostics

• Beckman Coulter
• Cepheid
• HemoCue
• Leica Biosystems
• Mammotome
• Masimo
• Radiometer

Life Sciences

• Abcam
• Beckman Coulter Life Sciences
• Genedata
• Integrated DNA Technologies
• IDBS
• Leica Microsystems
• Molecular Devices
• Pall
• Phenomenex
• SCIEX

Biotechnology

• Cytiva
• Aldevron
• Other specialised biotechnology businesses

Danaher’s current business directory provides the company’s broader portfolio of operating businesses.

---

32. Danaher Diagnostics vs Life Sciences

Area Diagnostics Life Sciences Main purpose Disease detection and monitoring Scientific research and discovery Users Hospitals, laboratories, clinicians Researchers, universities, pharma companies Products Diagnostic analysers, molecular tests, pathology systems Microscopes, mass spectrometers, research reagents Examples Beckman Coulter, Cepheid, Radiometer SCIEX, Leica Microsystems, Molecular Devices Main outcome Diagnostic information Scientific and therapeutic discoveries

---

33. Danaher vs a Traditional Medical-Device Company

Danaher is somewhat different from companies that mainly manufacture physical medical devices.

Its portfolio covers the complete scientific and healthcare chain:

Research → Discovery → Diagnostics → Drug Development → Biomanufacturing → Clinical Applications

This broad ecosystem is one of Danaher’s major strengths.

---

34. Danaher’s Global Presence

Danaher operates through businesses serving customers around the world.

The company reports that its businesses have research, manufacturing, sales, distribution, service and administrative facilities in more than 50 countries.

Its products and technologies are used by:

• Hospitals
• Diagnostic laboratories
• Universities
• Research institutions
• Pharmaceutical companies
• Biotechnology companies
• Government laboratories
• Contract research organisations
• Biopharmaceutical manufacturers

---

35. Danaher Revenue by Business Segment

Danaher’s 2025 full-year sales were: Segment 2025 Sales Diagnostics $9.941 billion Life Sciences $7.334 billion Biotechnology $7.293 billion Total$24.568 billion

Diagnostics was the largest of the three segments by 2025 revenue.

---

36. Danaher’s Role in Modern Healthcare

Danaher contributes to healthcare at several different levels.

A patient may benefit from Danaher technology without ever seeing the Danaher name.

For example:

A blood sample may be analysed using a Beckman Coulter system.

A molecular infection test may be performed using Cepheid technology.

A blood-gas test may use Radiometer equipment.

A cancer tissue sample may be processed using Leica Biosystems technologies.

A research laboratory may use SCIEX, Leica Microsystems or Molecular Devices equipment.

A pharmaceutical company may use Cytiva technologies to manufacture a biologic medicine.

This broad involvement makes Danaher one of the major science-and-technology ecosystems supporting modern healthcare.

---

Frequently Asked Questions

Is Danaher an American company?

Yes. Danaher Corporation is headquartered in Washington, D.C., United States.

What does Danaher manufacture?

Danaher operates through specialised businesses that develop diagnostic instruments, molecular testing systems, pathology technologies, microscopes, mass spectrometers, laboratory equipment, research reagents, bioprocessing systems and biotechnology manufacturing technologies.

Is Danaher a medical-device company?

Danaher is broader than a conventional medical-device company. It is a global science and technology company operating across Diagnostics, Life Sciences and Biotechnology.

What is Danaher best known for?

Danaher is particularly known for its broad portfolio of diagnostic, laboratory, life-science and bioprocessing companies, including Beckman Coulter, Cepheid, Cytiva, Leica Biosystems, SCIEX and Radiometer.

Does Danaher make diagnostic machines?

Yes. Through companies such as Beckman Coulter, Cepheid, HemoCue and Radiometer, Danaher provides clinical laboratory, molecular diagnostic and point-of-care systems.

Does Danaher make PCR testing systems?

Yes. Cepheid, part of Danaher’s Diagnostics segment, develops molecular diagnostic systems and tests based on technologies including PCR.

Does Danaher make microscopes?

Yes. Leica Microsystems, part of Danaher’s Life Sciences portfolio, develops scientific and research microscopes and related imaging technologies.

Does Danaher manufacture medicines?

Danaher primarily provides the technologies, tools, instruments and manufacturing systems used by pharmaceutical and biotechnology companies to discover, develop and manufacture medicines. It is not primarily a conventional finished-drug manufacturer.

What is Cytiva?

Cytiva is Danaher’s biotechnology business and provides technologies, services and expertise used in the development and manufacturing of biopharmaceutical products.

What is Beckman Coulter?

Beckman Coulter is a Danaher business that develops laboratory and diagnostic technologies used to automate and perform biomedical testing.

What is Cepheid?

Cepheid is a Danaher Diagnostics company focused on molecular diagnostic systems and tests, including the GeneXpert platform and Xpert assays.

How much revenue did Danaher report in 2025?

Danaher reported approximately $24.568 billion in 2025 total sales.

---

Conclusion

Danaher Corporation is much more than a conventional medical-equipment manufacturer. The American company has built a broad ecosystem spanning diagnostics, life sciences and biotechnology.

Its businesses provide technologies for clinical laboratories, molecular diagnostics, pathology, scientific research, drug discovery and biopharmaceutical manufacturing. Companies such as Beckman Coulter, Cepheid, HemoCue, Leica Biosystems, Radiometer, SCIEX, Cytiva, Abcam, Pall and Leica Microsystems give Danaher a presence across multiple stages of modern healthcare and scientific research.

From analysing a patient’s blood sample to developing a new biologic medicine, Danaher’s technologies can support different parts of the healthcare and scientific workflow. Its combination of specialised companies, scientific expertise and the Danaher Business System has made it one of the world’s major science and technology organisations serving human health.